… is enrolling patients to investigate the efficacy of ripretinib compared to sunitinib as second-line
… driver has resulted from breakthroughs in understanding the molecular basis of GIST. …

… the molecular basis of the interaction between sunitinib and AChE by using molecular … ,
thus far AChE inhibitors have not been particularly efficacious for the treatment of AD. (27) On the …

… Efficacy is well established for sunitinib as initial therapy for good-to-moderate prognosis
patients with metastatic renal cell cancers and a majority clear cell component. Benefits in …

… Sunitinib is a multi-kinase inhibitor that blocks receptor tyrosine kinase activity, including that
of vascular endothelial growth factor receptors (VEGFRs). Although sunitinib … of sunitinib on …

… metastatic RCC treated with sunitinib; even if NT-pro-BNP is not a molecule that interacts
directly … that we are talking about drugs, such as sunitinib, which have been shown to have toxic …

… most important purpose of sunitinib treatment is to maintain previous activities of daily living.
Maximum efficacy of antitumor therapy relates to sufficient dose and time. Sunitinib is a well-…

… Importantly, the clinical efficacy of sunitinib in ACC might be underestimated in our trial for
… of mitotane with sunitinib may have greatly reduced the exposure to sunitinib, as will be …

… its superior efficacy as measured … efficacy and safety of sunitinib in Chinese patients. In
this retrospective study, we report findings from an analysis of the efficacy and safety of sunitinib …

… significantly higher in the sunitinib arm (ORR 47 … sunitinib and IFN-α arms, respectively (P
= 0.051) [4, 13]. Here, we have investigated potential biomarkers of sunitinib and IFN-α efficacy …

… To our surprise, sunitinib showed only marginal ability to … variants were all sensitive to sunitinib
with comparable efficacy. … of the molecular basis of the pharmacokinetics of sunitinib and …